Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Samarin is an over-the-counter antacid and fruit salt product primarily used to treat heartburn and acid indigestion. It is a combination product typically containing sodium bicarbonate, citric acid, tartaric acid, and sodium carbonate. When dissolved in water, these ingredients react to form a buffering solution. In recent clinical research, Samarin has been investigated for a novel indication in obstetrics: the treatment of labor dystocia. The rationale is that bicarbonate acts as a lactic acid buffer; by reducing the accumulation of lactate in the myometrium (reflected by amniotic fluid lactate levels), it may enhance uterine contractile performance and reduce the necessity for emergency caesarean sections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Samarin.